一种利用先前BCG免疫接种的病毒疫苗设计,可以提供对埃博拉病毒的保护
Tony W Ng1, Wakako Furuyama2, Ariel S Wirchnianski1
1Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, United States.
Frontiers in immunology
|July 31, 2024
概括
这种新型抗病毒疫苗策略利用BCG疫苗接种中现有的CD4+辅助T细胞,增强抗体反应并提供对埃博拉病毒的保护. 这种方法为新出现的流行病提供了一种快速免疫方法.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 病毒学 病毒学
背景情况:
- 从Mycobacterium bovis bacille Calmette-Guérin (BCG) 疫苗接种中预先存在的CD4+辅助T (Th) 细胞可以用于抗病毒疫苗策略.
- 再组合融合蛋白结合病毒抗原和BCG Th细胞表位可以招募BCG诱导的Th细胞来帮助病毒特异性的B细胞.
研究的目的:
- 研究BCG诱导的Th细胞在抗体类切换和效应器功能中的作用.
- 评估基于BCG的疫苗策略在小鼠模型中对埃博拉病毒 (EBOV) 感染的疗效.
主要方法:
- 用含有病毒抗原和BCG Th细胞表位的复合融合蛋白进行免疫.
- 对Th细胞定位相对于生殖中心的分析.
- 对抗体类切换和Fc受体表达的评估.
- 在 EBOV 感染的小鼠模型中评估有效性.
主要成果:
- BCG诱导的Th细胞定位在生殖中心外,促进抗体类切换到具有强大的Fc受体相互作用的异型.
- 接种BCG疫苗上调了Fc受体表达,可能增强了抗体依赖的效应因子活动.
- 疫苗策略赋予了持续的抗体水平,具有强烈的IgG2c偏差,并保护小鼠免受致命的EBOV挑战.
结论:
- 这种疫苗策略有效地利用BCG诱导的Th细胞来增强抗病毒抗体反应并提供保护.
- 该方法适应各种病毒,并为BCG疫苗接种人群的流行病准备提供快速免疫方法.
关键词:
CD4+ T 细胞是 CD4+ T 细胞.埃博拉病毒埃博拉病毒.在Fc受体中,这种细菌是Mycobacterium bovis BCG.抗体是对抗体的重要组成部分.基础设施的帮助.疫苗,疫苗的使用情况.更多相关视频
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
10.6K
10:11Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
Published on: January 31, 2018
9.4K
相关概念视频
00:42Cross-reactivity
31.0K
Overview
31.0K
01:51Vaccinations
44.3K
Overview
44.3K
01:30Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
01:29Immune Response Against Viral Pathogens
766
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
766
01:23Immunological Memory
570
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
570